LJI research shows that a “slow delivery, escalating dose” vaccination strategy can prompt B cells to spend months mutating and evolving their pathogen-fighting antibodies.
The Center for Disease Control’s National Center for Immunization and Respiratory Diseases has awarded University Hospitals of Cleveland a sizable grant to support its assignment as a study site in the United States Flu Vaccine Effectiveness Network.
Scientists solve mystery of how Zika virus targets key immune cell. New finding shed light on how to stop virus from spreading.
An interdisciplinary team of doctors and engineers are working to develop a diagnostic test to detect severe COVID-19 complications.
Sylvester Comprehensive Cancer Center researcher Emmanuel Thomas, M.D., Ph.D., F.A.A.S.L.D., has been appointed to the National Institutes of Health’s (NIH) Coinfections and HIV Associated Cancers (HCAC) study section.
Just when it seemed like we could sit back and breathe a sigh of relief from declining COVID-19 rates in Nevada, another virus started making headlines: Monkeypox. Local COVID cases have been on a downward trajectory for more than a month. But a wastewater surveillance program led by UNLV Kirk Kerkorian School of Medicine professor and infectious disease expert Edwin Oh has started tracking monkeypox,making Southern Nevada among the first few metropolitan areas nationwide to begin searching the sewers for the emerging virus.
Sandra A. Kemmerly, MD, MACP, FIDSA joined the Ochsner staff in 1988 and is board certified in both internal medicine and infectious diseases. She maintains an active practice and is the clinical lead for Ochsner Healths Covid response in addition…
Dr. Baumgarten currently serves as Medical Director of Infection Control and Prevention for Ochsner Health since 2008, during which time she been involved in preventing transmissible diseases in the Ochsner System and our community. Over the past two years, she…
Health care facilities in Black metropolitan counties, Hispanic rural counties and hardest-hit counties were less likely to administer COVID-19 vaccines during initial rollout, UC San Diego study finds.
UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
Mayo Clinic Laboratories can now test for monkeypox, a rare viral infection, using the Centers for Disease Control and Prevention’s (CDC) orthopoxvirus test kit.
Scientists and physicians at UC San Diego and Scripps Research describe how wastewater sequencing provided dramatic new insights into levels and variants of SARS-CoV-2 on campus and in the broader community — a key step to public health interventions in advance of COVID-19 case surges.
UC San Diego researchers say they may have found the reason why multiple human clinical trials of staphylococcus vaccines have failed: the bacteria knows us too well.
Columbia University’s Global Alliance for Preventing Pandemics announces an agreement with the University of Zambia’s School of Veterinary Medicine and the U.S. Center for Disease Control and Prevention to train Zambian public health professionals to better identify and contain pathogen outbreaks.
In ACS Infectious Diseases, scientists now report that apratoxin S4, an anticancer drug candidate that targets a human protein, can interfere with the replication of many viruses, including SARS-CoV-2 and influenza A, offering a possible pan-viral therapy.
Elena Naumova, professor at the Friedman School of Nutrition Science and Policy at Tufts University, explains wastewater surveillance and testing, the underlying process and the pros and cons of its use.
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.
UC San Diego researchers report significant decrease in national cases of Kawasaki disease during COVID-19 pandemic; findings hint at origins of disease.
A UC San Diego study describes the short- and long-term neurological symptoms of SARS-CoV-2 infection, and identifies a new group of COVID-19 long-haulers with advanced motor and cognitive symptoms.
Q&A about monkeypox with Dr. Anne Rimoin, UCLA Fielding School of Public Health professor of epidemiology and the Gordon-Levin Endowed Chair in Infectious Diseases and Public Health, has been studying monkeypox for two decades.
The growing concern of recent outbreaks of the rare monkeypox virus reported in the U.S. and abroad have health authorities monitoring transmission rates and keeping a close eye on the emerging issue. Charles Schleupner, a professor of internal medicine who…
The United States has reached 1 million reported deaths from COVID-19 and that number is likely an undercount, according to the Centers for Disease Control and Prevention. The George Washington University has a number of experts to comment on the…
COVID-19, MIS-C and KD all share a similar underlying mechanism involving the over-activation of particular inflammatory pathways, UC San Diego study shows. Findings support novel drug targets for MIS-C.
Dr. Anne Rimoin, an internationally recognized expert on emerging infections, global health, infectious disease surveillance systems and vaccinations who has been engaged in pandemic preparedness and response work for more than two decades, has been appointed to the newly established Gordon–Levin Endowed Chair in Infectious Diseases and Public Health at the UCLA Fielding School of Public Health.
A new trial by UC San Diego Health infectious disease specialist Maile Young Karris, MD, will use longitudinal questionnaires and qualitative interviews to assess the impact of living in an interconnected virtual village on the loneliness known to afflict older people with HIV.
In the U.S., hepatitis A outbreaks are repeatedly affecting people experiencing homelessness or who use drugs. A 2017-19 Kentucky outbreak primarily among these groups resulted in 501 cases, six deaths. Vaccination efforts likely averted 30 hospitalizations and $490K in costs,…
Women who receive COVID-19 mRNA vaccines during pregnancy pass high levels of antibodies to their babies, a new NYU Langone study finds.
Sepsis occurs when the body works so hard to fight an infection that the immune system injures the patient’s own tissues. Detecting sepsis early and delivering antibiotics promptly is key to saving lives. UC San Diego Health researchers developed an…
Researchers at McMaster University have developed a sophisticated new tool that could help provide early warning of rare and unknown viruses in the environment and identify potentially deadly bacterial pathogens which cause sepsis, among other uses.
The most comprehensive analysis of the 3D structure of SARS-CoV-2 to date has revealed new insight on how the virus infects human cells and replicates.
Researchers found that breastfeeding mothers who received either the Pfizer-BioNTech or Moderna vaccination reported the same local or systemic symptoms as what has been previously reported in non-breastfeeding women, with no serious side effects in the breastfed infants.
A new research study reveals that Valley Fever, a fungal disease most commonly found in Arizona and California, may be more common in Utah than previously thought.
A study measured effectiveness of COVID-19 mRNA vaccines among health workers, most notably during the emergence of delta virus variant and coincident with end of state’s mask mandate, finding protection waned over time, dropping sharply 6-8 months after full vaccination.
UC San Diego is collaborating with San Ysidro Health on an NIH-funded outreach program to address COVID-19 vaccine hesitancy in Latinx and African American communities. The team runs pop-up vaccination sites across San Diego, and goes door-to-door to homes and local businesses to spread awareness.
Individuals with COVID-19 are most likely to spread the virus to close contacts two days before the onset of symptoms to three days after symptoms appear, and the risk of transmission is highest when patients had mild or moderate disease severity, according to a new study by researchers at the University of Georgia.
Each wave of the pandemic has underscored just how gravely contagious COVID-19 is, but there is less clarity among experts on exactly when—and to what extent—infected individuals are most likely to spread the virus.
Part of UC San Diego’s Return to Learn program, wastewater screening helped prevent outbreaks by detecting 85 percent of cases early, allowing for timely testing, contact tracing and isolation.
UC San Diego Health physicians describe first known case of young, healthy adult experiencing central nervous system inflammation due to COVID-19, but without cognitive impairment.
A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, reveals a study in the laboratory by an international collaboration of researchers.
UC San Diego researchers report that solid organ transplant recipients who were vaccinated experienced an almost 80 percent reduction in the incidence of symptomatic COVID-19 compared to unvaccinated counterparts during the same time.
The COVID-19 vaccine is your best defense against the virus, but when and where should you continue to wear a mask? Rush infectious disease expert Michael Lin, MD, answers questions about wearing a mask post-vaccination.
UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.
Advanced technologies have been used to solve a long-standing mystery about why some people develop serious illness when they are infected with the malaria parasite, while others carry the infection asymptomatically.
Researchers at UC San Diego School of Medicine and Rady Children’s Institute for Genomic Medicine have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus that causes COVID-19, into the human brain.
Using anonymized medical records from a national registry, UC San Diego researchers confirm earlier findings that statins may substantially minimize adverse outcomes from SARS-CoV-2 infection.
A new study out of UChicago found that while 43 states (out of 51, including all 50 states and Washington, D.C.) created a committee to develop a vaccine distribution plan, only 20 plans mentioned using a health equity committee to assist with plan development.
Researchers have found that viral vaccines grown in eggs, such as the H1N1 flu vaccine, produce an antibody response against a sugar molecule found in eggs, which could have implications for the effectiveness of these vaccines.
How common COVID-19 is among infants may depend on the degree of the pandemic virus circulating in a community, a new study finds.
UC San Diego Health is now offering a verifiable digital vaccine record to its patients who have or will receive a COVID-19 vaccine. These secure online records, otherwise known as a SMART health card, can be accessed directly from the MyUCSDChart patient portal.
MADISON – The presence of a state prison in a county was associated with 11% more COVID-19 cases through July 1, 2020, according to a new study from the University of Wisconsin–Madison.